Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracranial Wegener's granulomatosis

L M Weinberger1, M L Cohen, B F Remler

  • 1Department of Neurology, University Hospitals of Cleveland, OH.

Neurology
|September 1, 1993
PubMed
Summary

Wegener's granulomatosis (WG) can present atypically with brain and meningeal involvement. Early immunosuppressive therapy can effectively treat these rare, treatable intracranial complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The design and conduct of clinical trials to limit missing data.

Statistics in medicine·2012
Same author

A prototype cloud physics laser nephelometer.

Applied optics·2010
Same author

Evolution of oculomotor and clinical findings in autopsy-proven Richardson syndrome.

Neurology·2009
Same author

Foliar washoff of pesticides by rainfall.

Environmental science & technology·2009
Same author

Neuro-ophthalmological signs during rapid intravenous administration of phenytoin.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2008
Same author

Neuronal binucleation in Alzheimer disease hippocampus.

Neuropathology and applied neurobiology·2007

Area of Science:

  • Neurology
  • Immunology
  • Rheumatology

Background:

  • Wegener's granulomatosis (WG), a form of granulomatosis with polyangiitis, is an autoimmune vasculitis.
  • WG typically affects the respiratory tract and kidneys, but can have diverse systemic manifestations.

Observation:

  • This report details an unusual neurologic presentation of WG.
  • The patient exhibited significant meningeal and cerebral involvement.

Findings:

  • The patient's condition responded well to immunosuppressive therapy.
  • Intracranial complications occurred without typical WG signs (nasal/renal disease) or specific diagnostic markers (abnormal angiography, CSF pleocytosis, positive ANCA).

Implications:

  • WG should be considered in neurologic presentations even without classic symptoms.

Related Experiment Videos

  • Immunosuppressive therapy is a viable treatment for WG-related intracranial issues.
  • This case highlights the importance of considering WG in unexplained central nervous system vasculitis.